Repurposing alogliptin for ulcerative colitis: involvement of MicroRNAs, anti-inflammatory, and barrier-restoring mechanisms.

Saved in:
Bibliographic Details
Title: Repurposing alogliptin for ulcerative colitis: involvement of MicroRNAs, anti-inflammatory, and barrier-restoring mechanisms.
Authors: Alenezi MAG; Naif Al Nader Medical Pharmacies Group, Riyadh, Kingdom of Saudi Arabia., Ewees MGE; Department of Pharmacology and Toxicology, College of Pharmacy, Almaaqal University, 61014, Basrah, Iraq., El-Sayed EK; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Capital University (Formerly Helwan University), Ein Helwan-Cairo, Egypt., Morsy EME; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Capital University (Formerly Helwan University), Ein Helwan-Cairo, Egypt., Elbaz M; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Capital University (Formerly Helwan University), Ein Helwan-Cairo, Egypt. mohamad.elbaz@pharm.helwan.edu.eg.
Source: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2026 May; Vol. 399 (8), pp. 11745-11758. Date of Electronic Publication: 2026 Feb 23.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-1912
DOI:10.1007/s00210-026-05060-y